• Issues
    • Current Issue
    • Special Issues
  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Search
  • ASH Home
  • About ASH Clinical News
  • Authors
  • Advertising
  • Subscribe
  • Contact Us
  • eNewsletters
  • Cookie Settings
  • LOG IN
Welcome! Log into your account
Forgot your password?
Recover your password
ASH Clinical News
  • Issues
    • AllCurrent IssueSpecial Issues

      September 2021 Volume 7 Issue 11

      August 2021 Volume 7 Issue 10

      July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9

      July 2021 Volume 7 Issue 8

  • Viewpoints
    • Editor’s Corner
    • Advanced Practice Voices
    • From Our Readers
      • You Make the Call: Readers’ Response
      • Guest Commentary
      • Letters to the Editor
    • A Day in the Life
    • Notes From the Hill
    • The Break Room
  • Education
    • You Make the Call
    • Hematologica Obscura
    • How I Teach
    • How I Treat In Brief
    • Demystifying the Lab
    • Practice Update
  • Spotlight
    • Feature Articles
    • Pulling Back the Curtain
    • Blood Beyond Borders
    • pASHions
    • Drawing First Blood
    • HemOnc Link
    • Interviews
  • News
    • Online Exclusives
    • Latest & Greatest
    • From the Blood Journals
      • Written in Blood
      • Blood Advances in a Different Vein
    • Literature Scan
    • ASH Directions
    • The Society Pages
  • Topic Compilations
    • COVID-19 News
    • Acute Leukemias
    • Chronic Leukemias
    • MDS & Myeloproliferative Neoplasms
    • Multiple Myeloma & Plasma Cell Disorders
    • Lymphomas & Lymphoid Neoplasia
    • Bleeding Disorders
    • Clotting Disorders
    • Red Blood Cell & Iron Disorders
  • On Location
    • ASH Annual Meeting
    • ASH Meeting on Hematologic Malignancies
    • ASH Meeting on Lymphoma Biology
    • Other Meetings
  • Multimedia
    • Sound Bites
    • Meeting Coverage
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
    Christopher Flowers, MD

    Christopher Flowers, MD

    Department Chair, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
    • 2020 ASH Annual Meeting Preview: Conversations With Co-Chairs Monday, November 16th, 2020

      Education Program Co-chairs

    Sabrina Ahle
    Advertisement

    Current Issue

    September 2021 Volume 7 Issue 11

    Wednesday, September 1, 2021
    This issue discusses fertility preservation for young patients with cancer, reviews treatment options for primary immune thrombocytopenia, and more.

    Block title

    Zanubrutinib Approved for Waldenström Macroglobulinemia

    Sunday, September 12, 2021

    Two Decades After 9/11, Cancer and Other Chronic Conditions Linger

    Sunday, September 12, 2021

    FDA Grants Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

    Sunday, September 12, 2021

    Organizations Comment on the FDA’s Draft Guidance Expanding Clinical Trial Eligibility

    Wednesday, September 8, 2021

    Democrats Consider Plan to Cover Uninsured in Non-Medicaid Expansion States

    Wednesday, September 8, 2021
    Recent Posts
    • Zanubrutinib Approved for Waldenström Macroglobulinemia
    • Two Decades After 9/11, Cancer and Other Chronic Conditions Linger
    • FDA Grants Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma
    • Organizations Comment on the FDA’s Draft Guidance Expanding Clinical Trial Eligibility

    Meeting Coverage

    Researchers Validate Burkitt Lymphoma Prognostic Index

    Monday, March 1, 2021

    Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

    Monday, March 1, 2021

    Editor's Corner

    Editor’s Corner: Chance Encounters of the Third Kind

    Wednesday, September 1, 2021

    Sex Cells: The Forgotten Biological Variable

    Sunday, August 1, 2021
    2021 L Street NW, Suite 900, Washington, DC 20036
    Phone 202-776-0544 | Fax 202-776-0545
    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    Copyright © 2020 by American Society of Hematology

    Contact Us | Terms of Service | Privacy Policy